JPY 972.0
(-0.92%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 7.79 Billion JPY | -4.91% |
2022 | 8.2 Billion JPY | 1.05% |
2021 | 8.11 Billion JPY | -0.42% |
2020 | 8.14 Billion JPY | -8.78% |
2019 | 8.93 Billion JPY | 17.09% |
2018 | 7.63 Billion JPY | -14.72% |
2017 | 8.94 Billion JPY | 70.71% |
2016 | 5.24 Billion JPY | 6.24% |
2015 | 4.93 Billion JPY | 18.09% |
2014 | 4.17 Billion JPY | 6.67% |
2013 | 3.91 Billion JPY | 14.6% |
2012 | 3.41 Billion JPY | 0.7% |
2011 | 3.39 Billion JPY | 9.46% |
2010 | 3.1 Billion JPY | -26.06% |
2009 | 4.19 Billion JPY | -0.86% |
2008 | 4.22 Billion JPY | -6.32% |
2007 | 4.51 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 7.7 Billion JPY | -1.17% |
2023 Q2 | 7.94 Billion JPY | -2.01% |
2023 Q3 | 7.83 Billion JPY | -1.44% |
2023 Q4 | 7.79 Billion JPY | -0.45% |
2023 FY | 7.79 Billion JPY | -4.91% |
2023 Q1 | 8.11 Billion JPY | -1.1% |
2022 FY | 8.2 Billion JPY | 1.05% |
2022 Q4 | 8.2 Billion JPY | 3.48% |
2022 Q3 | 7.92 Billion JPY | -0.55% |
2022 Q1 | 8.33 Billion JPY | 2.67% |
2022 Q2 | 7.96 Billion JPY | -4.36% |
2021 Q2 | 8.33 Billion JPY | -5.99% |
2021 Q1 | 8.86 Billion JPY | 8.73% |
2021 FY | 8.11 Billion JPY | -0.42% |
2021 Q4 | 8.11 Billion JPY | 6.92% |
2021 Q3 | 7.59 Billion JPY | -8.89% |
2020 Q3 | 8.44 Billion JPY | -2.43% |
2020 Q1 | 8.88 Billion JPY | -0.58% |
2020 FY | 8.14 Billion JPY | -8.78% |
2020 Q4 | 8.14 Billion JPY | -3.52% |
2020 Q2 | 8.65 Billion JPY | -2.53% |
2019 Q1 | 8.09 Billion JPY | 6.12% |
2019 Q4 | 8.93 Billion JPY | 2.31% |
2019 Q3 | 8.73 Billion JPY | 15.22% |
2019 Q2 | 7.57 Billion JPY | -6.39% |
2019 FY | 8.93 Billion JPY | 17.09% |
2018 FY | 7.63 Billion JPY | -14.72% |
2018 Q2 | 7.64 Billion JPY | -5.75% |
2018 Q1 | 8.1 Billion JPY | -9.38% |
2018 Q4 | 7.63 Billion JPY | -3.94% |
2018 Q3 | 7.94 Billion JPY | 3.94% |
2017 Q1 | 5.32 Billion JPY | 1.56% |
2017 Q4 | 8.94 Billion JPY | 22.69% |
2017 Q3 | 7.29 Billion JPY | 31.76% |
2017 FY | 8.94 Billion JPY | 70.71% |
2017 Q2 | 5.53 Billion JPY | 3.99% |
2016 Q1 | 5.13 Billion JPY | 4.16% |
2016 Q4 | 5.24 Billion JPY | -5.49% |
2016 Q2 | 4.89 Billion JPY | -4.69% |
2016 Q3 | 5.54 Billion JPY | 13.23% |
2016 FY | 5.24 Billion JPY | 6.24% |
2015 Q4 | 4.93 Billion JPY | -2.8% |
2015 FY | 4.93 Billion JPY | 18.09% |
2015 Q3 | 5.07 Billion JPY | 9.29% |
2015 Q2 | 4.64 Billion JPY | 6.5% |
2015 Q1 | 4.36 Billion JPY | 4.38% |
2014 FY | 4.17 Billion JPY | 6.67% |
2014 Q4 | 4.17 Billion JPY | -2.7% |
2014 Q3 | 4.29 Billion JPY | 1.91% |
2014 Q2 | 4.21 Billion JPY | 3.45% |
2014 Q1 | 4.07 Billion JPY | 3.99% |
2013 Q2 | 3.58 Billion JPY | -5.07% |
2013 Q3 | 4.15 Billion JPY | 15.94% |
2013 Q1 | 3.77 Billion JPY | 10.38% |
2013 Q4 | 3.91 Billion JPY | -5.67% |
2013 FY | 3.91 Billion JPY | 14.6% |
2012 Q4 | 3.41 Billion JPY | -1.41% |
2012 Q1 | 3.74 Billion JPY | 10.29% |
2012 FY | 3.41 Billion JPY | 0.7% |
2012 Q2 | 3.45 Billion JPY | -7.72% |
2012 Q3 | 3.46 Billion JPY | 0.36% |
2011 Q4 | 3.39 Billion JPY | -6.54% |
2011 Q1 | 3.36 Billion JPY | 8.55% |
2011 Q2 | 3.28 Billion JPY | -2.3% |
2011 FY | 3.39 Billion JPY | 9.46% |
2011 Q3 | 3.63 Billion JPY | 10.42% |
2010 Q2 | 3.69 Billion JPY | -10.62% |
2010 Q3 | 3.72 Billion JPY | 0.88% |
2010 Q1 | 4.12 Billion JPY | -1.52% |
2010 FY | 3.1 Billion JPY | -26.06% |
2010 Q4 | 3.1 Billion JPY | -16.73% |
2009 Q3 | 4.76 Billion JPY | 10.77% |
2009 FY | 4.19 Billion JPY | -0.86% |
2009 Q4 | 4.19 Billion JPY | -12.08% |
2009 Q2 | 4.3 Billion JPY | 0.0% |
2008 Q3 | 5.03 Billion JPY | 0.0% |
2008 Q4 | 4.22 Billion JPY | -16.03% |
2008 FY | 4.22 Billion JPY | -6.32% |
2007 FY | 4.51 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -371.844% |
Euglena Co., Ltd. | 37.92 Billion JPY | 79.436% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | -20.111% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 46.517% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 63.503% |
Kao Corporation | 757.7 Billion JPY | 98.971% |
Niitaka Co., Ltd. | 9.35 Billion JPY | 16.654% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 92.134% |
Shiseido Company, Limited | 615.1 Billion JPY | 98.732% |
Lion Corporation | 188.22 Billion JPY | 95.857% |
Mandom Corporation | 20.05 Billion JPY | 61.118% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -487.747% |
Milbon Co., Ltd. | 7.45 Billion JPY | -4.54% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 42.492% |
Fancl Corporation | 30.56 Billion JPY | 74.489% |
KOSÉ Corporation | 88.61 Billion JPY | 91.2% |
Cota Co., Ltd. | 3.85 Billion JPY | -102.412% |
HABA Laboratories,Inc. | 3.92 Billion JPY | -98.726% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -147.653% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 76.554% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 67.563% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -632.853% |
Almado, Inc. | 1.94 Billion JPY | -300.653% |
I-ne CO., LTD. | 8.57 Billion JPY | 9.091% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | -59.799% |
Liberta Co.,Ltd. | 3.88 Billion JPY | -100.8% |
AXXZIA Inc. | 2 Billion JPY | -288.657% |
S.T. Corporation | 12.01 Billion JPY | 35.074% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 87.554% |
Earth Corporation | 60.4 Billion JPY | 87.09% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -383.446% |
Ya-Man Ltd. | 3.97 Billion JPY | -96.111% |
MTG Co., Ltd. | 11.73 Billion JPY | 33.57% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | -86.914% |
SHOBIDO Corporation | 8.89 Billion JPY | 12.353% |
Artnature Inc. | 23.42 Billion JPY | 66.713% |
Pigeon Corporation | 19.34 Billion JPY | 59.697% |
Unicharm Corporation | 345.37 Billion JPY | 97.742% |
Paltac Corporation | 222.34 Billion JPY | 96.493% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 72.651% |